FONDAPARINUX 5 MG/0.4 ML SYR Fondaparinux Sodium | 00781345495 | $55.3125 per ML | — | | — | Sandoz Inc. |
FONDAPARINUX 5 MG/0.4 ML SYR Fondaparinux Sodium | 55111067910 | $55.3125 per ML | — | | — | Dr. Reddy's Laboratories Inc. |
FONDAPARINUX 5 MG/0.4 ML SYR FONDAPARINUX SODIUM | 55150023110 | $55.3125 per ML | — | | — | Eugia US LLC |
FONDAPARINUX 5 MG/0.4 ML SYR fondaparinux sodium | 67457058304 | $55.3125 per ML | — | | — | Mylan Institutional LLC |
FONDAPARINUX 5 MG/0.4 ML SYR fondaparinux sodium | 70710151506 | $55.3125 per ML | — | | — | Zydus Pharmaceuticals (USA) Inc. |
FONDAPARINUX 10 MG/0.8 ML SYR Fondaparinux Sodium | 00781347695 | $45.3441 per ML | +2.32% | | — | Sandoz Inc. |
FONDAPARINUX 10 MG/0.8 ML SYR Fondaparinux Sodium | 55111068110 | $45.3441 per ML | +2.32% | | — | Dr. Reddy's Laboratories Inc. |
FONDAPARINUX 10 MG/0.8 ML SYR FONDAPARINUX SODIUM | 55150023310 | $45.3441 per ML | +2.32% | | — | Eugia US LLC |
FONDAPARINUX 10 MG/0.8 ML SYR fondaparinux sodium | 67457058508 | $45.3441 per ML | +2.32% | | — | Mylan Institutional LLC |
FONDAPARINUX 10 MG/0.8 ML SYR fondaparinux sodium | 70710151706 | $45.3441 per ML | +2.32% | | — | Zydus Pharmaceuticals (USA) Inc. |
FONDAPARINUX 7.5 MG/0.6 ML SYR Fondaparinux Sodium | 00781346595 | $42.9123 per ML | -1.06% | | — | Sandoz Inc. |
FONDAPARINUX 7.5 MG/0.6 ML SYR Fondaparinux Sodium | 55111068010 | $42.9123 per ML | -1.06% | | — | Dr. Reddy's Laboratories Inc. |
FONDAPARINUX 7.5 MG/0.6 ML SYR FONDAPARINUX SODIUM | 55150023210 | $42.9123 per ML | -1.06% | | — | Eugia US LLC |
FONDAPARINUX 7.5 MG/0.6 ML SYR fondaparinux sodium | 67457058406 | $42.9123 per ML | -1.06% | | — | Mylan Institutional LLC |
FONDAPARINUX 7.5 MG/0.6 ML SYR fondaparinux sodium | 70710151606 | $42.9123 per ML | -1.06% | | — | Zydus Pharmaceuticals (USA) Inc. |
FONDAPARINUX 7.5 MG/0.6 ML SYR Fondaparinux Sodium | 55111068002 | $20.9233 per ML | — | | — | Dr. Reddy's Laboratories Inc. |
FONDAPARINUX 7.5 MG/0.6 ML SYR fondaparinux sodium | 70710151609 | $20.9233 per ML | — | | — | Zydus Pharmaceuticals (USA) Inc. |
FONDAPARINUX 2.5 MG/0.5 ML SYR Fondaparinux Sodium | 00781344395 | $20.8396 per ML | +5.98% | | — | Sandoz Inc. |
FONDAPARINUX 2.5 MG/0.5 ML SYR Fondaparinux Sodium | 55111067810 | $20.8396 per ML | +5.98% | | — | Dr. Reddy's Laboratories Inc. |
FONDAPARINUX 2.5 MG/0.5 ML SYR FONDAPARINUX SODIUM | 55150023010 | $20.8396 per ML | +5.98% | | — | Eugia US LLC |
FONDAPARINUX 2.5 MG/0.5 ML SYR fondaparinux sodium | 67457058210 | $20.8396 per ML | +5.98% | | — | Mylan Institutional LLC |
FONDAPARINUX 2.5 MG/0.5 ML SYR fondaparinux sodium | 70710151406 | $20.8396 per ML | +5.98% | | — | Zydus Pharmaceuticals (USA) Inc. |
XARELTO 20 MG TABLET rivaroxaban | 50458057910 | $19.5615 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 20 MG TABLET rivaroxaban | 50458057930 | $19.5615 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 20 MG TABLET rivaroxaban | 50458057989 | $19.5615 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 20 MG TABLET rivaroxaban | 50458057990 | $19.5615 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 15 MG TABLET rivaroxaban | 50458057810 | $19.5286 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 15 MG TABLET rivaroxaban | 50458057830 | $19.5286 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 15 MG TABLET rivaroxaban | 50458057890 | $19.5286 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 10 MG TABLET rivaroxaban | 50458058010 | $19.5256 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 10 MG TABLET rivaroxaban | 50458058030 | $19.5256 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 10 MG TABLET rivaroxaban | 50458058090 | $19.5256 per EA | — | | | Janssen Pharmaceuticals Inc. |
FONDAPARINUX 10 MG/0.8 ML SYR Fondaparinux Sodium | 55111068102 | $18.3687 per ML | — | | — | Dr. Reddy's Laboratories Inc. |
FONDAPARINUX 10 MG/0.8 ML SYR fondaparinux sodium | 70710151709 | $18.3687 per ML | — | | — | Zydus Pharmaceuticals (USA) Inc. |
SAVAYSA 60 MG TABLET EDOXABAN TOSYLATE | 65597020330 | $14.6335 per EA | — | | — | Daiichi Sankyo Inc. |
SAVAYSA 30 MG TABLET EDOXABAN TOSYLATE | 65597020230 | $14.6052 per EA | +0.05% | | — | Daiichi Sankyo Inc. |
SAVAYSA 30 MG TABLET EDOXABAN TOSYLATE | 65597020205 | $12.4819 per EA | — | | — | Daiichi Sankyo Inc. |
SAVAYSA 30 MG TABLET EDOXABAN TOSYLATE | 65597020290 | $12.4819 per EA | — | | — | Daiichi Sankyo Inc. |
SAVAYSA 60 MG TABLET EDOXABAN TOSYLATE | 65597020305 | $12.4609 per EA | — | | — | Daiichi Sankyo Inc. |
SAVAYSA 60 MG TABLET EDOXABAN TOSYLATE | 65597020390 | $12.4609 per EA | — | | — | Daiichi Sankyo Inc. |
FONDAPARINUX 2.5 MG/0.5 ML SYR Fondaparinux Sodium | 55111067802 | $12.3868 per ML | -2.03% | | — | Dr. Reddy's Laboratories Inc. |
XARELTO 2.5 MG TABLET rivaroxaban | 50458057710 | $9.7776 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 2.5 MG TABLET rivaroxaban | 50458057718 | $9.7776 per EA | — | | | Janssen Pharmaceuticals Inc. |
XARELTO 2.5 MG TABLET rivaroxaban | 50458057760 | $9.7776 per EA | — | | | Janssen Pharmaceuticals Inc. |
ELIQUIS 5 MG TABLET apixaban | 00003089421 | $5.5228 per EA | -0.02% | | — | E.R. Squibb & Sons, L.L.C. |
ELIQUIS 5 MG TABLET apixaban | 00003089431 | $5.5228 per EA | -0.02% | | — | E.R. Squibb & Sons, L.L.C. |
ELIQUIS 5 MG TABLET apixaban | 00003089470 | $5.5228 per EA | -0.02% | | — | E.R. Squibb & Sons, L.L.C. |
ELIQUIS 2.5 MG TABLET apixaban | 00003089321 | $5.5161 per EA | 0.00% | | — | E.R. Squibb & Sons, L.L.C. |
ELIQUIS 2.5 MG TABLET apixaban | 00003089331 | $5.5161 per EA | 0.00% | | — | E.R. Squibb & Sons, L.L.C. |
XARELTO 1 MG/ML SUSPENSION rivaroxaban | 50458057501 | $3.7811 per ML | — | | | Janssen Pharmaceuticals Inc. |
RIVAROXABAN 1 MG/ML SUSPENSION Rivaroxaban | 67877088271 | $1.7938 per ML | -2.51% | | | Ascend Laboratories, LLC |
RIVAROXABAN 1 MG/ML SUSPENSION rivaroxaban granule | 70748035501 | $1.7938 per ML | -2.51% | | — | Lupin Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 33342048809 | $0.7967 per EA | -8.73% | | — | Macleods Pharmaceuticals Limited |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 33342048857 | $0.7967 per EA | -8.73% | | — | Macleods Pharmaceuticals Limited |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 43598098118 | $0.7967 per EA | -8.73% | | — | Dr. Reddy's Laboratories Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 43598098160 | $0.7967 per EA | -8.73% | | — | Dr. Reddy's Laboratories Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 50228051318 | $0.7967 per EA | -8.73% | | — | ScieGen Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 50228051360 | $0.7967 per EA | -8.73% | | — | ScieGen Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 51672422804 | $0.7967 per EA | -8.73% | | — | Sun Pharmaceutical Industries Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 51672422809 | $0.7967 per EA | -8.73% | | — | Sun Pharmaceutical Industries Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 59651084918 | $0.7967 per EA | -8.73% | | — | Aurobindo Pharma Limited |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 59651084960 | $0.7967 per EA | -8.73% | | — | Aurobindo Pharma Limited |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 60505625606 | $0.7967 per EA | -8.73% | | — | Apotex Corp. |
RIVAROXABAN 2.5 MG TABLET RIVAROXABAN | 62332068345 | $0.7967 per EA | -8.73% | | — | Alembic Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET RIVAROXABAN | 62332068360 | $0.7967 per EA | -8.73% | | — | Alembic Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET RIVAROXABAN | 68180070906 | $0.7967 per EA | -8.73% | | — | Lupin Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET RIVAROXABAN | 68180070909 | $0.7967 per EA | -8.73% | | — | Lupin Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET rivaroxaban | 71921040506 | $0.7967 per EA | -8.73% | | — | Florida Pharmaceutical Products, LLC |
RIVAROXABAN 2.5 MG TABLET rivaroxaban | 71921040521 | $0.7967 per EA | -8.73% | | — | Florida Pharmaceutical Products, LLC |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 76282077418 | $0.7967 per EA | -8.73% | | — | Exelan Pharmaceuticals Inc. |
RIVAROXABAN 2.5 MG TABLET Rivaroxaban | 76282077460 | $0.7967 per EA | -8.73% | | — | Exelan Pharmaceuticals Inc. |